Differential regulation of miR-146a/FASand miR-21/FASLGaxes in autoimmune lymphoproliferative syndrome due toFASmutation (ALPS-FAS)
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential regulation of miR-146a/FASand miR-21/FASLGaxes in autoimmune lymphoproliferative syndrome due toFASmutation (ALPS-FAS)
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 185, Issue 2, Pages 148-153
Publisher
Wiley
Online
2016-04-10
DOI
10.1111/cei.12800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells
- (2015) Ryan Charles Pink et al. GYNECOLOGIC ONCOLOGY
- miR-21 is a negative modulator of T-cell activation
- (2014) Claudia Carissimi et al. BIOCHIMIE
- Natural history of autoimmune lymphoproliferative syndrome associated withFASgene mutations
- (2014) Susan Price et al. BLOOD
- MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis
- (2014) Wenjia Wang et al. BMC CANCER
- The new world of RNAs
- (2014) Danyella Barbosa Dogini et al. GENETICS AND MOLECULAR BIOLOGY
- MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG
- (2014) Chao Shang et al. MOLECULAR BIOLOGY REPORTS
- MicroRNA-21 Identified as Predictor of Cancer Outcome: A Meta-Analysis
- (2014) Wenjie Zhu et al. PLoS One
- Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells
- (2013) Q. Guo et al. BLOOD
- Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia
- (2013) A. Rensing-Ehl et al. HAEMATOLOGICA
- miRNA*: A Passenger Stranded in RNA-Induced Silencing Complex?
- (2012) S. M. Mah et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance
- (2012) Amy P. Hsu et al. GENETICS IN MEDICINE
- Association of MicroRNA-146a with Autoimmune Diseases
- (2012) Wang-Dong Xu et al. INFLAMMATION
- The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer
- (2012) Catherine Labbaye et al. Journal of Hematology & Oncology
- MicroRNA Profiling in Mucosal Biopsies of Eosinophilic Esophagitis Patients Pre and Post Treatment with Steroids and Relationship with mRNA Targets
- (2012) Shaolei Lu et al. PLoS One
- FAS Haploinsufficiency Is a Common Disease Mechanism in the Human Autoimmune Lymphoproliferative Syndrome
- (2011) H. S. Kuehn et al. JOURNAL OF IMMUNOLOGY
- Regulation and function of miRNA-21 in health and disease
- (2011) Regalla Kumarswamy et al. RNA Biology
- Apoptosis and the target genes of microRNA-21
- (2011) Lindsey E. Becker Buscaglia et al. Chinese Journal of Cancer
- MicroRNA-21 protects neurons from ischemic death
- (2010) Ben Buller et al. FEBS Journal
- Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites
- (2010) Doron Betel et al. GENOME BIOLOGY
- An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes
- (2009) G. Curtale et al. BLOOD
- MicroRNA Control in the Immune System: Basic Principles
- (2009) Changchun Xiao et al. CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The Fas–FADD death domain complex structure unravels signalling by receptor clustering
- (2009) Fiona L. Scott et al. NATURE
- Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer
- (2009) K. Jazdzewski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started